Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PEGylated recombinant human hyaluronidase with nab-paclitaxel and gemcitabine versus placebo with nab-paclitaxel and gemcitabine in hya…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• PEGylated recombinant human hyaluronidase (pegylated recombinant human hyaluronidase)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Pancreatic Ductal Carcinoma | Phase 3 | Status: TERMINATED | Results posted: 2020-07-14